17 records – page 1 of 1.

Tamper Resistance under the Controlled Drugs and Substances Act

https://policybase.cma.ca/link/policy11295
Date
2014-08-26
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.

https://policybase.cma.ca/link/policy11814
Date
2016-01-20
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Health care and patient safety

Front-of-package labelling consultation

https://policybase.cma.ca/link/policy13800
Date
2016-10-31
Topics
Health care and patient safety
Policy Type
Response to consultation
Date
2016-10-31
Topics
Health care and patient safety
Documents
Less detail

Regulation of Self-Care Products in Canada

https://policybase.cma.ca/link/policy13802
Date
2016-10-31
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Health care and patient safety

Consultation on the renewal of Federal Tobacco Control Strategy

https://policybase.cma.ca/link/policy13804
Date
2017-04-05
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Health Canada’s Consultation on “Plain and Standardized Packaging”

https://policybase.cma.ca/link/policy13817
Date
2016-08-12
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Consultation on proposed front-of-package labelling

https://policybase.cma.ca/link/policy13882
Date
2018-04-23
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Health Canada consultation on tobacco products regulations (plain and standardized appearance)

https://policybase.cma.ca/link/policy13930
Date
2018-09-06
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Implementation of National Pharmacare

https://policybase.cma.ca/link/policy13933
Date
2018-10-02
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Health Canada’s consultation on new health-related labelling for tobacco products

https://policybase.cma.ca/link/policy13939
Date
2018-12-14
Topics
Health care and patient safety
Population health, health equity, public health

Health Canada consultation on the impact of vaping products advertising on youth and non-users of tobacco products

https://policybase.cma.ca/link/policy14022
Date
2019-03-22
Topics
Health care and patient safety
Population health, health equity, public health

Health Canada consultation on vaping products labelling and packaging regulations

https://policybase.cma.ca/link/policy14124
Date
2019-09-05
Topics
Health care and patient safety
Population health, health equity, public health

Health Canada consultation on potential market for cannabis health products that would not require practitioner oversight

https://policybase.cma.ca/link/policy14125
Date
2019-09-03
Topics
Health care and patient safety
Population health, health equity, public health

Health Canada consultation on proposed vaping products promotion regulations

https://policybase.cma.ca/link/policy14128
Date
2020-01-20
Topics
Health care and patient safety
Population health, health equity, public health

Insite: CMA submission regarding Insite supervised injection site and program.

https://policybase.cma.ca/link/policy14129
Date
2011-02-17
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Clinical guideline for homeless and vulnerably housed people, and people with lived homelessness experience

https://policybase.cma.ca/link/policy14165
Date
2019-10-17
Topics
Health care and patient safety
Population health, health equity, public health

The Canadian Interdisciplinary Palliative Care Competency Framework

https://policybase.cma.ca/link/policy14439
Date
2020-12-05
Topics
Health care and patient safety
Population health, health equity, public health

17 records – page 1 of 1.